2011
DOI: 10.1002/humu.21581
|View full text |Cite
|
Sign up to set email alerts
|

Extending the scope of diagnostic chromosome analysis: Detection of single gene defects using high-resolution SNP microarrays

Abstract: Microarray analysis has provided significant advances in the diagnosis of conditions resulting from submicroscopic chromosome abnormalities. It has been recommended that array testing should be a "first tier" test in the evaluation of individuals with intellectual disability, developmental delay, congenital anomalies, and autism. The availability of arrays with increasingly high probe coverage and resolution has increased the detection of decreasingly small copy number changes (CNCs) down to the intragenic or … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
44
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 43 publications
(47 citation statements)
references
References 22 publications
2
44
1
Order By: Relevance
“…The LCSH data facilitated the identification of a pathogenic, homozygous sequence mutation that confirmed the clinical diagnosis of a specific monogenic disorder in four cases (described in detail in Bruno et al 21). The LCSH encompassing the causative sequence mutation(s) ranged in size from 2.2 megabases to 17 megabases.…”
Section: Resultsmentioning
confidence: 64%
“…The LCSH data facilitated the identification of a pathogenic, homozygous sequence mutation that confirmed the clinical diagnosis of a specific monogenic disorder in four cases (described in detail in Bruno et al 21). The LCSH encompassing the causative sequence mutation(s) ranged in size from 2.2 megabases to 17 megabases.…”
Section: Resultsmentioning
confidence: 64%
“…The power of shifting the cytogenetic approach to the identification of monogenic dominant or recessive causes of developmental disorders by high resolution SNP technology up to an additional detection rate of about 0.2% has been recently demonstrated (Bruno et al, 2011). The current progress in the use of high-throughput sequencing technologies, however, and the realistic perspective of its introduction in a clinical setting may promise a superior approach.…”
Section: Discussionmentioning
confidence: 98%
“…The four previously reported large deletions were identified in Pakistan, India, England and Germany. 9,10,14 The 67-kb deletion identified here in our patient is a novel mutation detected by SNP array analysis from Saudi Arabia.…”
Section: Discussionmentioning
confidence: 83%